N/A Completed N=31 Health Services Research

Motivation and Skills Support (MASS)

Schizophrenia · schizoaffective disorder

Source: ClinicalTrials.gov NCT03404219 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2021

Primary outcomePrimary: Changes in Social Functioning as Measured by the Social Functioning Scale (SFS) — 108.00 score on a scale — p=0.09

Summary

Social impairment contributes to more severe symptoms, higher rates of hospitalization, and increased disability in persons with schizophrenia. In this study the investigators will develop a smartphone application and test its impact on improving real-world social functioning in persons with schizophrenia. Findings from this study will allow researchers and clinicians to better understand ways to improve social skills and social motivation, two common problems in the daily lives of persons with schizophrenia. The investigators hope this mobile phone-based support application will ultimately contribute to increased access to effective treatments for social functioning in this population.

Outcome Measures

Outcome	Result	p-value
PRIMARY Changes in Social Functioning as Measured by the Social Functioning Scale (SFS)	108.00	0.09
PRIMARY Changes in Social Engagement as Measured by the Quality of Life Scale (QLS) - Interpersonal Relations Subscale.	2.60	—
SECONDARY Changes in Experience-Sampling-Based Self-Reports of Social Appraisals	1.35	—

Eligibility Criteria

Inclusion Criteria

•All participants with schizophrenia or schizoaffective disorder (identified either by self-report and confirmatory chart diagnosis, or by using the Structured Clinical Interview for DSM-5 [SCID-5]) will be in good general physical health, between 18 and 65 years old (as to not confound developmental issues with our focus), and fluent in English. Subjects do not need to have a significant other in order to participate in the study.

Exclusion Criteria

•All participants with a current (past 6 months) substance use disorder, which will be determined by administration of the SCID-5, and self-reported current suicidal ideation with intent and/or a plan (assessed using attached instrument; i.e., "High" risk) or diagnosis of a neurological disorder.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03404219). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.